Piloting Health
Piloting Health, hosted by Bob Hariri M.D., Ph.D., is a new tool to help educate inform and excite you about the breakthroughs that are happening in biotechnology. Particularly around focuses like cellular and regenerative medicine, analytics, bioinformatics and data science. This is a new evolution in what we can do to treat serious diseases and also enhance the quality of your life as you age. Looking forward to having you board for the flight.
Piloting Health
Ozempic and the Effects of Caloric Restriction
Why do drugs like Ozempic work? In this episode of Piloting Health, Dr. Frank Dos Santos joins me once again for an in-depth look at the most talked-about drugs on the market right now: GLP-1 agonists.
We break down exactly why the drugs cause weight loss, but also how that weight loss can lead to a reduced change of certain types of diseases. What is it about caloric restriction that can help stave off disease? In this vein, we also talk intermittent fasting and I even espouse my theory that the body encourages fasting when combatting certain types of cancer.
It goes without saying that any decision to begin any type of drug or medical regiment needs to be discussed with your physician, so we're not advocating for any individual to begin GLP-1 agonists or fasting but, in general, the results we're seeing from caloric restriction seem to be very positive in many circumstances. In this episode, Dr. Dos Santos and I break down exactly why.
To follow Dr. Dos Santos, you can find him on Instagram:
@drfrankdossantos
Follow Dr. Bob Hariri on his platforms here:
Web: www.pilotinghealth.com
Instagram: https://www.instagram.com/drbobhariri/
X: https://twitter.com/DrBobHariri
TikTok: https://www.tiktok.com/@pilotinghealth
LinkedIn: https://www.linkedin.com/in/drbobhariri/